http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111417647-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71610c23a5e221cfcf1f5a52e4c7df5e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate | 2018-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2edfffc53a16c2387ad9f9e22bf73c45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2249583240df6f05a7b67fdbe7ae359 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ce4010e5a975742adcf87ef3095b27b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcb499a1849ed16162d0ac3bd381f06c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da756b89db845be7cb9724811a01d9fa |
| publicationDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111417647-A |
| titleOfInvention | Novel senolytic peptides |
| abstract | Artificial senolytic peptides that selectively kill senolytic cells in a mammal upon intermittent administration, a method of stimulating rejuvenation in a safe manner. In addition, methods of using the artificial senolytic peptides to treat senescence-associated diseases and disorders by selectively killing senescent cells. Killing senescent cells reduces the inflammatory senescence-associated secretory phenotype, thereby significantly reducing chronic inflammation in the metabolism. Diseases and conditions that can be treated with the senolytic peptides include diseases of all inflammatory origins, including but not limited to diabetes, cardiovascular disease, pulmonary disease, including COPD; asthma, emphysema, dyspnea; renal or hepatic insufficiency, cirrhosis, osteoarthritis; aging-related ophthalmic diseases and disorders; skin diseases and disorders associated with aging, diabetic ulcers; kyphosis; scoliosis; weight loss; hair loss; muscle loss; loss of bone density; frailty and/or decreased health; hearing loss such as deafness. |
| priorityDate | 2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 563.